These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 19587349

  • 21. The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett's oesophagus.
    Abu-Sneineh A, Tam W, Schoeman M, Fraser R, Ruszkiewicz AR, Smith E, Drew PA, Dent J, Holloway RH.
    Aliment Pharmacol Ther; 2010 Oct; 32(8):1023-30. PubMed ID: 20937048
    [Abstract] [Full Text] [Related]

  • 22. [Clinical and instrumental characteristics of the gastroesophageal reflux in children with bronchial asthma, possibilities of therapy].
    Apenchenko IuS, Gnusaev SF, Rozov DN, Ivanova II.
    Eksp Klin Gastroenterol; 2010 Oct; (9):58-62. PubMed ID: 21427926
    [Abstract] [Full Text] [Related]

  • 23. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
    Bajbouj M, Becker V, Phillip V, Wilhelm D, Schmid RM, Meining A.
    Digestion; 2009 Oct; 80(2):112-8. PubMed ID: 19641320
    [Abstract] [Full Text] [Related]

  • 24. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV, Beliaeva VS.
    Eksp Klin Gastroenterol; 2007 Oct; (3):83-91. PubMed ID: 17937011
    [No Abstract] [Full Text] [Related]

  • 25. Distension during gastroesophageal reflux: effects of acid inhibition and correlation with symptoms.
    Tipnis NA, Rhee PL, Mittal RK.
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G469-74. PubMed ID: 17556589
    [Abstract] [Full Text] [Related]

  • 26. Effect of antireflux treatment on asthma exacerbations in nonatopic children.
    Khoshoo V, Haydel R.
    J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):331-5. PubMed ID: 17325553
    [Abstract] [Full Text] [Related]

  • 27. Gastroesophageal reflux-related chronic laryngitis: con.
    Vaezi MF.
    Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):908-9. PubMed ID: 20855684
    [No Abstract] [Full Text] [Related]

  • 28. [Antisecretory potential of pantoprasole (sanpraz)].
    Kurilovich SA, Chernosheĭkina LE.
    Eksp Klin Gastroenterol; 2008 Sep; (7):119-22. PubMed ID: 19334455
    [No Abstract] [Full Text] [Related]

  • 29. [Use of omeprazole and esomeprazole in patients suffering from bronchial asthma with associated gastroesophageal reflux disease].
    Maev IV, Viuchnova ES, Balashova NN, Shchekina MI.
    Eksp Klin Gastroenterol; 2003 Sep; (3):26-31, 116. PubMed ID: 14556543
    [Abstract] [Full Text] [Related]

  • 30. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
    Peng S, Xiong LS, Xiao YL, Wang AJ, Lin JK, Hu PJ, Chen MH.
    Chin Med J (Engl); 2010 Aug 05; 123(15):2012-7. PubMed ID: 20819534
    [Abstract] [Full Text] [Related]

  • 31. Changes in gene expression of gastric mucosa during therapeutic acid inhibition.
    Nørsett KG, Laegreid A, Kusnierczyk W, Langaas M, Ylving S, Fossmark R, Myhre S, Falkmer S, Waldum HL, Sandvik AK.
    Eur J Gastroenterol Hepatol; 2008 Jul 05; 20(7):613-23. PubMed ID: 18679062
    [Abstract] [Full Text] [Related]

  • 32. Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor.
    Hershcovici T, Jha LK, Cui H, Powers J, Fass R.
    Aliment Pharmacol Ther; 2011 Apr 05; 33(7):837-44. PubMed ID: 21261670
    [Abstract] [Full Text] [Related]

  • 33. [METHODOLOGICAL FEATURES OF THE pH-METRY IN PATIENTS WITH A COMBINATION OF GASTROESOPHAGEAL REFLUX DISEASE AND BRONCHIAL ASTHMA].
    Kazyulin AN, Dicheva DT, Parcvania-Vinogradova EV, Andreev DN.
    Eksp Klin Gastroenterol; 2016 Apr 05; (6):100-4. PubMed ID: 30280848
    [Abstract] [Full Text] [Related]

  • 34. Gastroesophageal reflux disease and asthma: the role of proton pump inhibitors.
    Menon MS, Al-Hajji M, Morice A.
    Chest; 2006 Jun 05; 129(6):1732; author reply 1732-3. PubMed ID: 16778299
    [No Abstract] [Full Text] [Related]

  • 35. Review article: is stringent control of gastric pH useful and practical in GERD?
    Kahrilas PJ.
    Aliment Pharmacol Ther; 2004 Oct 05; 20 Suppl 5():89-94; discussion 95-6. PubMed ID: 15456470
    [Abstract] [Full Text] [Related]

  • 36. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.
    Dent J, Vakil N, Jones R, Bytzer P, Schöning U, Halling K, Junghard O, Lind T.
    Gut; 2010 Jun 05; 59(6):714-21. PubMed ID: 20551454
    [Abstract] [Full Text] [Related]

  • 37. In brief: Esomeprazole strontium.
    Med Lett Drugs Ther; 2014 Jul 21; 56(1447):64. PubMed ID: 25046421
    [No Abstract] [Full Text] [Related]

  • 38. The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH.
    Junghard O, Hassan-Alin M, Hasselgren G.
    Eur J Clin Pharmacol; 2002 Oct 21; 58(7):453-8. PubMed ID: 12389067
    [Abstract] [Full Text] [Related]

  • 39. A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease.
    Johnson DA, Stacy T, Ryan M, Wootton T, Willis J, Hornbuckle K, Brooks W, Doviak M.
    Aliment Pharmacol Ther; 2005 Jul 15; 22(2):129-34. PubMed ID: 16011671
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease.
    Omari T, Davidson G, Bondarov P, Nauclér E, Nilsson C, Lundborg P.
    J Pediatr Gastroenterol Nutr; 2007 Nov 15; 45(5):530-7. PubMed ID: 18030229
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.